山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (8): 130-132.doi: 10.6040/j.issn.1671-7554.0.2022.0041
• 病例报道 • 上一篇
洪慧1,2,张卫海2,李惠娴2,3,李伟伟2,张金岭2,4
中图分类号:
| [1] Yamamoto K, Takano K, Kondo A, et al. Clinical and prognostic analysis of hypopharyngeal squamous cell carcinoma with syn-chronous and metachronous multiple malignancies[J]. In Vivo, 2018, 32(1): 165-170. [2] Zhai C, Cai Y, Lou F, et al. Multiple primary malignant tumorsa clinical analysis of 15,321 patients with malignancies at a single center in China [J]. J Cancer, 2018, 9(16): 2795-2801. [3] Working Group Report. International rules for multiple primary cancers(ICD-0 third edition)[J]. Eur J Cancer Prev, 2005, 14(4): 307-308. [4] Internationnal Association of Cancer Registries. International rules for multiple primary cancers[J]. Asian Pac J Cancer Prev, 2005, 6(1): 104-106. [5] Kim BK, Oh SJ, Song JY, et al. Clinical characteristics and prognosis associated with multiple primary cancers in breast cancer patients[J]. J Breast Cancer, 2018, 21(1): 62-69. [6] Lv M, Zhang X, Shen Y, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors[J]. Medicine(Baltimore), 2017, 96(17): e6799. [7] Utada M, Ohno Y, Hori M, et al. Incidence of multiple primary cancers and interval between first and second primary cancers[J]. Cancer Sci, 2014, 105(7): 890-896. [8] Coyte A, Morrison DS, McLoone P. Second primary cancer risk- the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study [J]. BMC Cancer, 2014, 14: 272. doi: 10.1186/1471-2407-14-272. [9] 王玮, 周志伟, 万德森,等. 多原发大肠癌70例临床分析[J].癌症,2008, 27(5): 505-509. WANG Wei, ZHOU Zhiwei, WAN Deseng, et al. Clinical analysis of 70 cases of multiple primary colorectal carcinoma [J].Chinese Journal of Cancer, 2008, 27(5): 505-509. [10] Sert F, Caner A, Haydaroglu A. Trends in the incidence and overall survival of multiple primary cancers in Turkey [J]. J BUON, 2020, 25(2): 1230-1236. [11] Si L, Feng Y, Wang Y, et al. Clinical and pathological characteristics of multiple primary malignant neoplasms cases [J]. Int J Clin Pract, 2021, 75(11): e14663. [12] Wang H, Hou J, Zhang G, et al. Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer [J]. Cancer Gene Ther, 2019, 26(11-12): 419-426. [13] Ventura L, Carbognani P, Gnetti L, et al. Multiple primary malignancies involving lung cancer: a single-center experience [J]. Tumori, 2021, 107(3): 196-203. [14] 张帅,许志云,董高超,等. 肺癌合并其他器官多原发癌的临床特点分析[J]. 中国肺癌杂志,2021,24(1):7-12. ZHANG Shuai, XU Zhiyun, Dong Gaochao, et al. Analysis of clinical characteristics of lung cancer combined with multiple primary malignancies in other organs[J]. Chin J Lung Cancer, 2021, 24(1): 7-12. |
| [1] | 殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73. |
| [2] | 韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31. |
| [3] | 蔡佳莹,王靖婷,王增萍,王璟,郏雁飞,马晓丽. α5-nAChR对慢性应激肺腺癌荷瘤小鼠疑核c-Fos表达的影响[J]. 山东大学学报 (医学版), 2025, 63(4): 69-74. |
| [4] | 王靖婷,王璟,鲁艺,李静坦,李强,郏雁飞,马晓丽. α5-nAChR与MHC-I在肺腺癌中的表达及相关性[J]. 山东大学学报 (医学版), 2024, 62(5): 72-78. |
| [5] | 杨闯,张荣雨,宋彬,王程君,赵文,玄甜甜,李际盛. 阿美替尼一线治疗EGFR突变肺腺癌伴大疱性类天疱疮1例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(12): 32-37. |
| [6] | 孟健丽,王庆港. 生物信息学方法探讨VPS72在肺腺/鳞癌中的表达及潜在作用机制[J]. 山东大学学报 (医学版), 2023, 61(8): 40-49. |
| [7] | 杜圣红,李晓梅,陈晨,王玲. 鼻型弥漫大B细胞淋巴瘤合并肺腺癌1例并文献复习[J]. 山东大学学报 (医学版), 2023, 61(8): 111-115. |
| [8] | 刘士标,张淑君,李培龙,杜鲁涛,王传新. cg20657709位点甲基化对肺腺癌早期诊断的初步探讨[J]. 山东大学学报 (医学版), 2023, 61(4): 18-25. |
| [9] | 赵启迪,王凯,赵小刚,闫涛,王亚东,杜贾军. 基于SEER数据库构建并验证IIIB期非小细胞肺癌患者预后模型[J]. 山东大学学报 (医学版), 2023, 61(10): 23-37. |
| [10] | 郑昊天,王光辉,赵小刚,王亚东,曾榆凯,杜贾军. 基于数据库LKB1突变肺腺癌DNA异常甲基化位点构建的预后风险模型[J]. 山东大学学报 (医学版), 2022, 60(3): 51-58. |
| [11] | 柴小雪,叶辉,吕欣然,丁续超,甄秋来,杜娟,曹莉莉. POU4F3表达对118例肺腺癌患者预后评估及对肺腺癌细胞株迁移的影响[J]. 山东大学学报 (医学版), 2021, 59(11): 8-18. |
| [12] | 庞兆飞,柳勇,赵小刚,闫涛,陈效伟,杜贾军. 基于公共数据库构建肺腺癌肿瘤干性评分模型预测免疫治疗疗效[J]. 山东大学学报 (医学版), 2021, 59(11): 19-28. |
| [13] | 杨秀婷,刘启功,左萍,刘正湘,左后娟. CD151-MUT突变对肺腺癌细胞A549迁移的影响及机制[J]. 山东大学学报 (医学版), 2020, 58(3): 81-86. |
| [14] | 郑清月,赵秋红,渠香云,董肇楠,马雪情,贾云莉. 血清外泌体miR-205-5p/miR-152-5p对早期非小细胞肺癌的诊断价值[J]. 山东大学学报 (医学版), 2019, 57(10): 101-106. |
| [15] | 谢厚耐,李猛,许林,王晖,彭岳,彭忠民. 吉非替尼对比培美曲塞联合顺铂治疗术后EGFR突变阳性Ⅱ~ⅢA期肺腺癌的临床分析[J]. 山东大学学报 (医学版), 2018, 56(9): 29-34. |
|
||
